CHDR Annual Report 2022
Contents 2022
  • Homepage
  • 2022 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2022 stories
Other years

Developing drugs

CHDR’s research groups made vital contributions to the development of new drugs in 2022. In this we are proud to collaborate with a range of valued clients and partners, some of whom also share their stories below.

Profiling novel GABA agonists

‘I really enjoyed brainstorming with the CHDR team’ — Dr Beate Rohde, Bayer

Patients and healthy volunteers in an integrative approach to drug development in oncology

‘It’s been a fantastic journey’ — Dr Thomas Holm Pedersen, NMD pharma

Unlocking the potential of psychedelic compounds in psychiatry

‘It’s exciting when the pieces of the puzzle fall into place’ — Dr Rachel Gurrell, Noema Pharma

‘CHDR is an active and innovative research partner’ — Dr Peter van der Ark, Janssen

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl
  • Download report as PDF

Text

Pieter van Megchelen

Editing

Echt English

Photography and video

Michiel Plas, Maarten Slooves, Samantha Prins

Design

JUST — wearejust.com